Abstract
References
1.
Griffith
TM
,
Edwards
DH
,
Lewis
MS
,
Henderson
AH.
Evidence that cyclic guanosine monophosphate (cGMP) moderates endothelium-dependent relaxation . Eur J Pharmacol 1985 ; 112 : 195 –202 .
2.
Ziegler
JW
,
Ivy
DD
,
Fox
JJ
,
Kinsella
JP
,
Clarke
WR
,
Abman
SH.
Dipyridamole, a cGMP phosphodiesterase inhibitor causes pulmonary vasodilation in the ovine fetus . Am J Physiol 1995 ; 269 : H473 –9 .
3.
Al-Alaiyan
Al Omran
,
Dyer
D.
The use of phosphodiesterase inhibitor (dipyridamole) to wean from inhaled nitric oxide . Intent Car Med 1996 ; 22 : 1093 –5 .
4.
Ivy
DD
,
Kinsella
JP
,
Ziegler
JW
,
Abman
SH.
Dipyridamole attenuates rebound pulmonary hypertension after inhaled nitric oxide withdrawal in postoperative congenital heart disease . J Thorac Cardiovasc Surg 1998 ; 115 : 875 –82 .
5.
Kinsella
JP
,
Torielli
F
,
Ziegler
JW
,
Ivy
DD
,
Abman
SH.
Dipyridamole augmentation of response to nitric oxide . Lancet 1995 ; 346 : 647 –8 .
6.
Ivy
DD
,
Ziegler
JW
,
Kinsella
JP
,
Wiggins
JW
,
Abman
SH.
Haemodynamic effects of dypyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension . Chest 1998 ; 114 (1 suppl): 17S .